Ginkgo Bioworks buys North Carolina startup's gene therapy platform
The future of a North Carolina-based gene therapy company founded by a Duke University professor is unclear now that it has sold its main platform.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news